Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
about
A comparison of N-glycan profiles in human plasma and vitreous fluid.Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and diseaseInflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.Change in N-Glycosylation of Plasma Proteins in Japanese SemisupercentenariansFetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation AnalysisThe role of glycosylation in IBD.Predicting outcomes in acute severe ulcerative colitis.Intact glycopeptide characterization using mass spectrometry.Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes.Short Communication: Increase of Sialylated N-Glycansin Eyes with Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy.Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.
P2860
Q35184247-8CB8AAEC-2151-4FC0-A767-82B873B9A906Q35241750-06B49783-B8EA-4679-886B-8B1AC906F277Q35670608-4B84F052-EC50-40D0-BEF6-2209C07D826AQ35838843-D2705494-5067-4193-B781-4E42901B9EB2Q35983444-5081E9E3-4034-4C8F-ABDF-BA1DAF65D6E7Q38218832-7A4E1D6D-5406-428B-9B73-D9FC52E11E6BQ38286166-70E6D900-B3FB-40AE-8AFB-58379DEA2D2AQ38824113-D18A3591-A785-4901-B6F8-4BC1DE1B93E7Q40041917-3937262A-9EE1-46BD-BEDA-2140E9A2E8EBQ40733791-A4C299AE-624E-4297-8812-B588EB695D1BQ41573946-2BFDD3D0-354F-4743-A61D-56FA8B9DB002Q45072735-43C8DCE0-B483-4D78-969E-70F140043F4EQ55491567-9C78CE7E-23F5-490B-BEBF-9F6F0B6F239D
P2860
Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@ast
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@en
type
label
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@ast
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@en
prefLabel
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@ast
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@en
P2093
P2860
P1433
P1476
Serum glycan markers for evalu ...... ients with ulcerative colitis.
@en
P2093
Akinobu Takaki
Fusao Ikeda
Hidenori Shiraha
Hiroyuki Okada
Kazuhide Yamamoto
Kazuhiro Nouso
Kazuko Hirose
Keita Harada
Koji Miyahara
Maho Amano
P2860
P304
P356
10.1371/JOURNAL.PONE.0074861
P407
P577
2013-10-07T00:00:00Z